HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinya Yamamoto Selected Research

Disease Progression

4/2022Clinical Outcome and Prognostic Variables of Second-line Therapy for Patients With Castration-resistant Prostate Cancer After Failure of First-line Androgen Receptor Axis-targeted Therapy.
12/2016Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinya Yamamoto Research Topics

Disease

50Neoplasms (Cancer)
02/2024 - 06/2004
38Prostatic Neoplasms (Prostate Cancer)
11/2023 - 06/2004
22Renal Cell Carcinoma (Grawitz Tumor)
05/2023 - 03/2009
22Neoplasm Metastasis (Metastasis)
07/2022 - 08/2006
16Breast Neoplasms (Breast Cancer)
03/2024 - 01/2014
10COVID-19
11/2023 - 02/2021
8Carcinoma (Carcinomatosis)
12/2021 - 05/2006
7Infections
11/2023 - 07/2006
5Lymphatic Metastasis
01/2024 - 12/2007
5Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 10/2008
5Fibrosis (Cirrhosis)
01/2024 - 11/2005
4Proteinuria
03/2024 - 02/2021
4Inflammation (Inflammations)
11/2022 - 11/2005
4Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2021 - 12/2007
3Neurodevelopmental Disorders
12/2023 - 01/2018
3Virus Diseases (Viral Diseases)
09/2023 - 01/2022
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2015
3Glomerulonephritis
02/2021 - 11/2013
3Ischemia
12/2020 - 02/2008
3Mitochondrial Diseases (Mitochondrial Disease)
01/2016 - 01/2015
3Pneumonia (Pneumonitis)
01/2013 - 08/2006
2Microcephaly
01/2024 - 04/2023
2Pain (Aches)
12/2023 - 08/2015
2Inborn Genetic Diseases (Disease, Hereditary)
07/2023 - 01/2020
2Sepsis (Septicemia)
04/2022 - 02/2018
2Fever (Fevers)
04/2022 - 01/2013
2Disease Progression
04/2022 - 12/2016
2Pyoderma Gangrenosum
09/2021 - 08/2015
2Mental Disorders (Mental Disorder)
10/2019 - 01/2014
2Margins of Excision
11/2018 - 05/2014

Drug/Important Bio-Agent (IBA)

13Prostate-Specific Antigen (Semenogelase)IBA
03/2021 - 06/2004
12Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2012
9C-Reactive ProteinIBA
07/2022 - 11/2011
8AndrogensIBA
03/2021 - 05/2010
8Cisplatin (Platino)FDA LinkGeneric
01/2021 - 09/2008
7NivolumabIBA
03/2024 - 08/2017
7Tyrosine Kinase InhibitorsIBA
09/2023 - 04/2011
7Etoposide (VP 16)FDA LinkGeneric
01/2021 - 09/2008
6Biomarkers (Surrogate Marker)IBA
07/2023 - 06/2014
6IfosfamideFDA LinkGeneric
01/2021 - 09/2008
5pembrolizumabIBA
01/2024 - 07/2019
5VaccinesIBA
12/2023 - 02/2021
5Antiviral Agents (Antivirals)IBA
11/2023 - 11/2013
5Sunitinib (Sutent)FDA Link
05/2021 - 04/2011
5GemcitabineFDA Link
03/2021 - 11/2012
4AntibodiesIBA
03/2024 - 01/2014
4Immune Checkpoint InhibitorsIBA
01/2024 - 11/2020
4mRNA VaccinesIBA
11/2023 - 05/2022
4Testosterone (Sustanon)FDA Link
03/2021 - 09/2007
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
03/2021 - 05/2008
4Zoledronic Acid (Zometa)FDA Link
12/2016 - 03/2009
3Bevacizumab (Avastin)FDA Link
03/2024 - 12/2023
3Paclitaxel (Taxol)FDA LinkGeneric
12/2023 - 03/2020
3SteroidsIBA
11/2022 - 08/2011
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2022 - 11/2013
3Monoclonal AntibodiesIBA
02/2022 - 01/2012
3cabazitaxelFDA Link
01/2021 - 10/2019
3Docetaxel (Taxotere)FDA Link
01/2021 - 11/2011
3Hormones (Hormone)IBA
08/2015 - 08/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2024 - 12/2023
2olaparibIBA
11/2023 - 06/2023
2Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2023 - 06/2019
2GlucocorticoidsIBA
09/2023 - 08/2006
2Prednisolone (Predate)FDA LinkGeneric
08/2023 - 09/2021
2Complementary DNA (cDNA)IBA
01/2023 - 11/2005
2EnzymesIBA
11/2022 - 02/2008
2CreatinineIBA
11/2022 - 01/2011
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2022 - 12/2021
2Phenobarbital (Luminal)FDA Link
03/2022 - 02/2015
2N-methyl-valyl-amiclenomycin (BA 2)IBA
02/2022 - 01/2022
2COV2-2130IBA
02/2022 - 01/2022
2N-(2-cyanoethylene)urea (BA 1)IBA
02/2022 - 01/2022
2COV2-2196IBA
02/2022 - 01/2022
2molnupiravirIBA
02/2022 - 01/2022
2nirmatrelvirIBA
02/2022 - 01/2022
2fibrin fragment D (D-dimer)IBA
02/2021 - 01/2020
2Adenosine Triphosphate (ATP)IBA
01/2021 - 12/2020
2Axitinib (AG 013736)IBA
11/2020 - 07/2017
2enzalutamideIBA
10/2020 - 01/2016
2Immunoglobulins (Immunoglobulin)IBA
06/2019 - 08/2017
2Immune Checkpoint ProteinsIBA
01/2019 - 08/2017
2DenosumabFDA Link
12/2016 - 01/2012
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 01/2015

Therapy/Procedure

30Therapeutics
03/2023 - 08/2006
20Prostatectomy (Retropubic Prostatectomy)
01/2022 - 07/2007
16Drug Therapy (Chemotherapy)
12/2023 - 12/2007
10Castration
11/2023 - 05/2008
10Nephrectomy
01/2023 - 02/2008
7Radiotherapy
02/2022 - 12/2007
5Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 09/2008
3Mastectomy (Mammectomy)
03/2024 - 01/2015
3Cystectomy
01/2024 - 10/2008
3Neoadjuvant Therapy
01/2024 - 01/2022
3Lymph Node Excision (Lymph Node Dissection)
09/2021 - 01/2015
2Renal Dialysis (Hemodialysis)
08/2023 - 11/2022
2Negative-Pressure Wound Therapy
12/2022 - 09/2021
2Molecular Targeted Therapy
05/2021 - 05/2012
2Aftercare (After-Treatment)
01/2019 - 08/2011
2Ligation
11/2018 - 07/2007
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2015 - 06/2014